Synthesis of Gold-Capped Mesoporous Silica Nanocarriers to Enhance Chemotherapeutic Efficacy Through Green Light Photodynamic Therapy
Abstract
Porous silica nanocarriers have gained prominence for the delivery of various anticancer drugs due to their excellent surface functionalization capabilities and potential to mitigate undesirable side effects. In this study, gold nanoparticles were synthesized through a seed-mediated growth method (with diameters ranging from 7 to 10 nm) and conjugated onto mesoporous silica nanocarriers via amine-gold interactions. The large pore channels of nanocarriers were efficiently loaded with the anticancer drug doxorubicin. Physicochemical characterization was comprehensively performed using dynamic light scattering, scanning transmission electron microscopy, Fourier transform infrared spectroscopy, and an absorption spectrophotometer. The mesoporous silica nanocarriers demonstrated a rod-shaped morphology, approximately 150 nm in length and 100 nm in width. Leveraging the strong optical absorption of gold nanoparticles at 530 nm, the synergistic effect of green-light-mediated photodynamic therapy and chemotherapy was investigated on prostate cancer cells. The co-therapies successfully reduced cell viability by 54% at a concentration of 400 µg/mL nanocarriers after 10 minutes of green light exposure (540 nm, 100 mW/cm², continuous wave), demonstrating the potential of this minimally invasive treatment strategy. Our findings suggest that gold-decorated porous silica nanocarriers can effectively act as a multifunctional platform by merging chemotherapy and photodynamic therapy to enhance cancer treatment outcomes.
Keywords
Mesoporous silica nanoparticles, gold nanoparticles, chemotherapy, photodynamic therapy, prostate cancer
Supporting Institution
This study was supported by Haliç University.
Ethical Statement
No approval from the Board of Ethics is required.
Thanks
The authors thank Assist. Prof. Dr Mustafa K. Ruhi for his valuable supports from the Biophotonics Laboratory (Boğazici University).
References
- B. Wang, S. Hu, Y. Teng, J. Chen, H. Wang, Y. Xu, K. Wang, J. Xu, Y. Cheng, X. Gao, Current advance of nanotechnology in diagnosis and treatment for malignant tumors, Signal Transduction and Targeted Therapy 9 (1) (2024) 200.
- V. K. Chaturvedi, A. Singh, V. K. Singh, M. P. Singh, Cancer nanotechnology: A new revolution for cancer diagnosis and therapy, Current Drug Metabolism 20 (6) (2019) 416–429.
- K. B. Seljak, P. Kocbek, M. Gašperlin, Mesoporous silica nanoparticles as delivery carriers: An overview of drug loading techniques, Journal of Drug Delivery Science and Technology 59 (2020) 101906.
- T. Li, S. Shi, S. Goel, X. Shen, X. Xie, Z. Chen, H. Zhang, S. Li, X. Qin, H. Yang, C. Wu, Y. Liu, Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer, Acta Biomaterialia 89 (2019) 1–13.
- M. Gisbert-Garzarán, M. Vallet-Regí, Influence of the surface functionalization on the fate and performance of mesoporous silica nanoparticles, Nanomaterials 10 (5) (2020) 916.
- A. Watermann, J. Brieger, Mesoporous silica nanoparticles as drug delivery vehicles in cancer, Nanomaterials 7 (7) (2017) 189.
- S. Mohanan, C.I. Sathish, K. Ramadass, M. Liang, A. Vinu, Design and synthesis of cabazitaxel loaded core-shell mesoporous silica nanoparticles with different morphologies for prostate cancer therapy, Small 20 (39) (2024) 2303269.
- Y. Zhao, Y. Wang, F. Ran, Y. Cui, C. Liu, Q. Zhao, Y. Gao, D. Wang, S. Wang, A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics, Scientific Reports 7 (1) (2017) 4131.
- L. Sutrisno, K. Ariga, Pore-engineered nanoarchitectonics for cancer therapy, NPG Asia Materials 15 (2023) 21.
- C. M. Liu, G. B. Chen, H. H. Chen, J. B. Zhang, H. Z. Li, M. X. Sheng, W. B. Weng, S. M. Guo, Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment, Colloids and Surfaces B: Biointerfaces 175 (2019) 477–486.